PHASE-I AND PHASE-II TRIAL OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE IN PATIENTS WITH ACUTE-LEUKEMIA

被引：0

作者：

ARLIN, ZA ^{[1
]}

SKLAROFF, RB ^{[1
]}

GEE, TS ^{[1
]}

KEMPIN, SJ ^{[1
]}

HOWARD, J ^{[1
]}

CLARKSON, BD ^{[1
]}

YOUNG, CW ^{[1
]}

机构：

[1] MEM SLOAN KETTERING CANC CTR,DEPT MED,DEV CHEMOTHERAPY SERV,NEW YORK,NY 10021

来源：

CANCER RESEARCH | 1980年 / 40卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3304 / 3306

页数：3

共 50 条

[41] IDENTIFICATION OF CONJUGATION AND CLEAVAGE PRODUCTS IN THE THIOLYTIC METABOLISM OF THE ANTI-CANCER DRUG 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE
PRZYBYLSKI, M
CYSYK, RL
SHOEMAKER, D
ADAMSON, RH
BIOMEDICAL MASS SPECTROMETRY, 1981, 8 (10): : 485 - 491
[42] STUDIES ON THE FLUORESCENCE LABELING OF HUMAN RED BLOOD-CELL MEMBRANE GHOSTS WITH 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE
WONG, A
CROOKE, ST
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) : 3265 - 3273
[43] COMPARATIVE CARDIAC OXYGEN RADICAL METABOLISM BY ANTHRACYCLINE ANTIBIOTICS, MITOXANTRONE, BISANTRENE, 4'-(9-ACRIDINYLAMINO)-METHANESULFON-META-ANISIDIDE, AND NEOCARZINOSTATIN
DOROSHOW, JH
DAVIES, KJA
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (19) : 2935 - 2939
[44] ENHANCEMENT OF VIRAL GROWTH BY THE ANTI-TUMOR DRUG 4'-(9-ACRIDINYLAMINO) METHANESULFON-META-ANISIDIDE (M-AMSA)
DRAKE, S
FURLONG, NB
NELSON, JA
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (17) : 2615 - 2618
[45] PHASE-I AND PRELIMINARY PHASE-II STUDIES ON ACLACINOMYCIN-A IN PATIENTS WITH ACUTE-LEUKEMIA
SUZUKI, H
KAWASHIMA, K
YAMADA, K
MINAMI, S
KATO, Y
TANIMOTO, M
YAMADA, H
ISOBE, K
HAYASHI, K
YAMAGUCHI, H
TAKAMATSU, J
WATANABE, E
KODERA, Y
SHIKU, H
KAMIYA, T
OHNO, R
MORISHITA, H
YOKOMAKU, S
YOSHIDA, K
OGURA, M
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1980, 10 (01) : 111 - 117
[46] PHASE-II STUDY OF AMSA (ACRIDINYLAMINO-METHANESULFON-M-ANISIDIDE) IN LYMPHOPROLIFERATIVE DISORDERS
CABANILLAS, F
LEGHA, S
BODEY, GP
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 156 - 156
[47] A PHASE-II TRIAL OF 4'-(9-ACRIDINYLAMINO)-METHANESULFON-M-ANISIDIDE (AMSA) IN PATIENTS WITH RENAL-CELL CARCINOMA (RCC) AND REFRACTORY SMALL CELL-CARCINOMA OF THE LUNG (SCCL)
FUKS, JZ
VANECHO, DA
AISNER, J
KRAVITZ, S
WIERNIK, PH
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 477 - 477
[48] PHASE-II EVALUATION OF 4'-(9-ACRIDINYLAMINO)-METHANESULFON-M-ANISIDINE (AMSA) IN PATIENTS WITH ADVANCED HEAD AND NECK CANCERS
RATANATHARATHORN, V
DRELICHMAN, A
SEXONPORTE, M
ALSARRAF, M
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (01): : 29 - 32
[49] AMSACRINE [4'-(9-ACRIDINYLAMINO)-METHANESULFON-META-ANISIDIDE] (META-AMSA) AND 5-AZACYTIDINE (AZA) FOR REMISSION REINDUCTION IN PATIENTS WITH RELAPSED ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA - AN ECOG PILOT-STUDY
KAHN, SB
SPIERS, A
KNOSPE, WH
SOOJIAN, M
GLICK, JH
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (01): : 78 - 81
[50] EFFECTIVENESS OF 4'-(9-ACRIDINYLAMINO) METHANESULFON-META-ANISIDIDE (META-AMSA) ALONE OR IN COMBINATION WITH RADIATION ON MURINE FIBRO-SARCOMA PULMONARY NODULES
HUNTER, N
GRDINA, D
JONES, S
RADIATION RESEARCH, 1982, 91 (02) : 346 - 346

← 1 2 3 4 5 →